In the CAMK2A-EZH2-SOX2 pathway (Fig. 6m), CAMK2A is the only factor specifically expressed in tumor but not normal lung, and thus might be a relatively safe treatment target compared with non-specifically inhibiting EZH2 and SOX2. The gene discussed is SOX2; the disease is neoplasm.